Please complete the CAPTCHA to continue
A concise factual answer block for searchers comparing this professional profile.
Daniel Lindén is listed as Senior Principal Scientist (Sr Director Bioscience) at AstraZeneca at AstraZeneca, a with 59317 employees, based in Greater Gothenburg Metropolitan Area, Sweden. AeroLeads shows a matched LinkedIn profile for Daniel Lindén.
Daniel Lindén previously worked as Senior Principal Scientist (Sr Director Bioscience) at Astrazeneca and Principal Investigator at Astrazeneca. Daniel Lindén holds Associate Professor, Physiology At Sahlgrenska Academy from University Of Gothenburg.
This section adds company-level context without repeating Daniel Lindén's masked contact details.
Review company-level records connected to Daniel Lindén before choosing the right outreach path.
Extensive experience from being Project Leader and Bioscience Leader in all phases of pre-clinical drug discovery projects in Diabetes, NASH, Obesity, and Cardiovascular disease (small molecules, antibodies, and antisense) and from being a Line Manager with excellent communication skills. For publication list, please see Google Scholar and Researchgate.
Listed skills include Drug Discovery, Pharmacology, In Vivo, Metabolism, and 28 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Gothenburg, Sweden
Senior Principal Scientist and Senior Director at Bioscience Metabolism, Research and Early Development Cardiovascular, Renal and Metabolism (Early CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Cvmd Imed, Gothenburg, Sweden
2019-Present, co-PI for graduate student Oveis Jamialahmadi together with Prof. Stefano Romeo, Dept of Molecular and Clinical Medicine, Göteborg University, Sweden.2018-2022, co-PI for postdoc Kay Liu together with Dr. Alan Sabirsh, AZ and Prof. Anna Salvati, Dept of Nanomedicine & Drug Targeting, University of Groningen, The Netherlands.2016-2019, co-PI for postdoc Sebastian Prill together with Prof. Stefano Romeo, Dept of Molecular and Clinical Medicine, Göteborg University, Sweden. 2014-2016, Principal Investigator for postdoc Amy Warner together with Dr Patrick Seale at the School of Medicine, University of Pennsylvania.2007-2008, Principal Investigator for postdoc's Per-Arne Svensson and Anna Ljungberg together with Professor's Lena Carlsson and Jan Borén at the Sahlgrenska Center for Cardiovascular and Metabolic Research and Wallenberg Laboratory for Cardiovascular Research, Göteborg University, Sweden. 2001-2006, Co-supervisor for graduate student Anna Ljungberg at Wallenberg Laboratory for Cardiovascular Research, Göteborg University, Sweden. Thesis with the title: “The role of PPAR alpha on growth hormone in hepatic lipid metabolism and atherosclerosis” defended 8th June 2006.1997-2007, Supervisor/ co-supervisor for 10 graduate students.
Cvmd Imed, Gothenburg, Sweden
Associate Director and Principal Scientist at the Bioscience Diabetes department. Department representative in joint disease and core research teams with Ionis Pharmaceuticals developing antisense therapies for diabetes and NASH.
Cvmd Imed, Gothenburg, Sweden
Project Leader and Bioscience Leader for pre-clinical drug discovery projects in Diabetes and NASH.
Cvmd Imed, Gothenburg, Sweden
Team leader at the department of Bioscience working with drug discovery projects in diabetes and obesity. Project leader for a monoclonal antibody project targeting FGFR1c aimed for the treatment of obesity. Principal investigator for research collaboration with Professor Hans-Rudolf Berthoud at Pennington Biomedical Research Center in Baton Rouge, USA. Bioscience leader for a small molecule project antagonizing MCHR1 delivering a clinical candidate drug for the treatment of obesity.
Principal investigator for collaboration with Professor Domenico Accili at Columbia University Medical Center in New York on a novel approach to treat diabetes.
Columbia University Medical Center, New York
Secondment for one year working with Dr. Anthony Ferrante on adipose tissue inflammation in relation to insulin sensitivity as part of a strategic alliance collaboration at Columbia University Medical Center in New York.
Cvgi R&D, Sweden
Team leader for different pharmacology teams at the department of Bioscience working with drug discovery projects in diabetes, obesity, dyslipidemia, and diabetic nephropathy.
Cvgi R&D, Sweden
Senior scientist working with dyslipidemia at the department of Integrative Pharmacology.
Cvgi R&D, Sweden
Postdoc working with obesity at the department of Integrative Pharmacology. Principal investigator; Professor Leonard Storlien.
Other employees you can reach at astrazeneca.com. View company contacts for 59317 employees →
Renata Piskorska
Colleague at AstrazenecaLublin, Lubelskie, Poland
View →
ME
Maria Emmerick, Md, Msc, Mhsc
Colleague at AstrazenecaNiterói, Rio De Janeiro, Brazil
View →
HH
Henderson, Hernon
Colleague at AstrazenecaCharlottesville, Virginia, United States
View →
GC
Gamaliel Claudio
Colleague at AstrazenecaUnited States
View →
LS
Luis Sosa
Colleague at AstrazenecaPuerto Rico
View →
SL
Sophie Lebuhotel
Colleague at AstrazenecaFrance
View →
MN
Masahiro Nii
Colleague at AstrazenecaKyoto, Japan
View →
HB
Haley Biggs
Colleague at AstrazenecaGreater Evansville Area, United States
View →
ŦH
Ŧlorina Huruglica
Colleague at AstrazenecaSödertälje, Stockholm County, Sweden
View →
B(
Bethany (Dutra) Kaplan
Colleague at AstrazenecaBoston, Massachusetts, United States
View →
PhD in Medicine. Title of my Thesis: “Growth hormone and PPAR alpha in the regulation of lipoprotein metabolism”.
Quick answers generated from the profile data available on this page.
Daniel Lindén works for AstraZeneca.
Daniel Lindén is listed as Senior Principal Scientist (Sr Director Bioscience) at AstraZeneca at AstraZeneca.
Daniel Lindén is based in Greater Gothenburg Metropolitan Area, Sweden while working with AstraZeneca.
Daniel Lindén has worked for Astrazeneca and Columbia University Medical Center.
Daniel Lindén's colleagues at AstraZeneca include Renata Piskorska, Maria Emmerick, Md, Msc, Mhsc, Henderson, Hernon, Gamaliel Claudio, and Luis Sosa.
You can use AeroLeads to view verified contact signals for Daniel Lindén at AstraZeneca, including work email, phone, and LinkedIn data when available.
Daniel Lindén holds Associate Professor, Physiology At Sahlgrenska Academy from University Of Gothenburg.
Daniel Lindén is listed with skills including Drug Discovery, Pharmacology, In Vivo, Metabolism, Drug Development, Animal Models, Diabetes, and Life Sciences.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contactsCheck these profiles if this is not the Daniel Lindén you were looking for.
